PVP Ventures Limited

PVP Ventures Limited

41.56
INR
-1.76
(-4.06%)
0.05EPS
154.44P/E
7.72BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
2.59
2.18
6.04
6.35
2.4
1.51
1.79
0.73
2
7.17
0.33
1.04
3.45
4.54
Basic EPS, GAAP
0.11
-1.04
0.01
0.34
-2.54
-2.74
-3.83
-2.31
-2.44
5.87
2.64
-0.26
-0.26
0.19
Free Cash Flow per Basic Share
-0.91
2.67
1.04
1.73
-0.34
-0.54
0.71
0.25
-0.54
13.36
- -
0.75
-3.32
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
17.43
8.78
9.58
10.14
8.65
5.3
2.77
0.46
-1.87
6.04
8.81
8.53
8.38
- -
Tangible Book Value per Share
14.07
8.78
9.58
10.14
8.65
5.29
2.77
0.46
-1.87
6.04
7.4
7.37
0.14
- -
Basic Weighted Avg Shares
245
245
245
245
244
244
244
244
244
245
254
260
260
260
Sales/Revenue/Turnover
635
534
1,479
1,556
584
368
437
178
488
1,757
85
272
897
1,181
Operating Margin (%)
25.95
-94.19
23.14
28.09
-17.2
-122.64
-51.05
-84.35
13.2
73.02
-130.62
-34.42
9.94
7.7
Depreciation Expense
2
6
12
11
11
17
25
20
9
11
19
20
137
188
Net Income, GAAP
28
-254
3
82
-621
-669
-934
-564
-595
1,438
670
-67
-68
50
Effective Tax Rate (%)
65.83
- -
92.82
- -
- -
- -
- -
- -
- -
9.44
- -
- -
- -
70.21
Profit Margin (%)
4.42
-47.62
0.22
5.28
-106.22
-181.72
-213.53
-316.05
-121.97
81.84
790.87
-24.75
-7.58
4.23
Working Capital
-785
2,224
3,179
3,079
2,625
1,680
292
-606
-1,853
1,558
-39
147
100
- -
LT Debt
1,646
1,342
1,693
1,851
2,035
2,412
1,859
1,457
1,285
17
29
20
1,621
- -
Total Equity
4,283
2,084
2,760
2,842
2,222
908
-39
-845
-1,796
1,082
2,296
2,203
3,973
- -
Return on Invested Capital (%)
0.91
- -
0.67
- -
- -
- -
- -
- -
- -
99.78
- -
- -
- -
- -
Return on Capital (%)
1.66
- -
1.77
- -
- -
- -
- -
- -
- -
28
- -
- -
- -
- -
Return on Common Equity (%)
0.65
-7.91
0.15
3.4
-26.95
-39.14
-94.6
-143.08
- -
- -
35.49
-2.98
-3.09
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
951
- -
LT Borrowings
- -
1,423
- -
LT Finance Leases
- -
198
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
260
260
260
Market Capitalization
9,671
6,109
7,721

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
1,455
- -
Cash, Cash Equivalents & STI
- -
513
- -
Accounts Receivable, Net
- -
261
- -
Inventories
- -
542
- -
Total Current Liabilities
- -
1,355
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
951
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
200.81%
28.19%
80.37%
Free Cash Flow
4,873.9%
9,805.25%
-542.13%
Net Income, GAAP
106.92%
-99.74%
0.97%
Sales/Revenue/Turnover
65.46%
157.86%
229.78%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
25
32
25
190
272
2026
172
171
140
414
897
2027
456
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.09
-0.1
-0.02
-0.06
-0.26
2026
0.01
-0.12
-0.14
-0.01
-0.26
2027
0.46
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Prasad Veera Potluri
Full Time Employees
20
Sector
Technology services
Industry
Information technology services
Address
Punnaiah Plaza, Plot No. 83 and 84 Hyderabad TN India 500034
IPO Date
Mar 23, 2000
Business
PVP Ventures Limited PVP Ventures Limited (NSE: PVP.NS), incorporated in 1991 and headquartered in Hyderabad, India, operates as a holding company focused on healthcare services, urban infrastructure development, and strategic investments across real estate and related ventures. The company delivers healthcare solutions through a portfolio of specialized brands and subsidiaries, including Orange Imaging & Diagnostics for teleradiology and diagnostics, DOC Medical Services for clinical care, Humain Sai Labs for genomics and advanced biotechnology, Noble Diagnostics Private Limited, Apta Medical Imaging Private Limited, and Humain Healthtech Private Limited; it also provides real estate development services encompassing residential and commercial projects, alongside legacy interests in media and entertainment such as movie production and financing. PVP Ventures maintains operations primarily in India, targeting Tier 2 and Tier 3 markets with technology-driven healthcare offerings in cancer care, senior care, dialysis, diagnostics, and wellness, while monetizing real estate assets through development partnerships. In a strategic pivot from real estate toward building a house of healthcare brands, the company agreed in August 2025 to acquire a majority stake in dialysis provider 7Med India Pvt. Ltd. and Epitome Group of kidney-care hospitals for Rs 127 crore, starting with 41.23% and scaling to 76% subject to financial milestones; it further committed in November 2024 to purchase a 52% stake in Biohygea Global Private Limited for Rs 70 million to bolster biotechnology and diagnostic capabilities. To fund healthcare expansion, PVP Ventures partners with developers including Brigade Enterprises Ltd., Casagrand Premier Builder Ltd., Casa Builders Private Limited, and Rainbow Foundations Limited for joint ventures expected to generate over Rs 2,000 crore in cash flows over six years from legacy realty assets.